View in EDS HTML Full Text PDF Full Text

Post-COVID-19 Burden of Severe Influenza in England Among Overall Population and High-Risk Groups: Results From the INFORM Study, 2022-2023.

Saved in:
Bibliographic Details
Title: Post-COVID-19 Burden of Severe Influenza in England Among Overall Population and High-Risk Groups: Results From the INFORM Study, 2022-2023.
Authors: Meeraus W; Medical Evidence, Vaccines & Immune Therapies, AstraZeneca, Eastbrook House, Shaftesbury Road, Cambridge, CB2 8DU, UK. wilhelmine.meeraus@astrazeneca.com., Carty L; BPM Evidence Statistics, Real World Science and Analytics, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK., Dube S; Medical Evidence, Vaccines & Immune Therapies, AstraZeneca, Eastbrook House, Shaftesbury Road, Cambridge, CB2 8DU, UK., Evans K; Thermo Fisher Scientific, Waltham, MA, USA., Evans RA; Department of Respiratory Sciences, NIHR Biomedical Research Centre-Respiratory Theme, University of Leicester, Leicester, UK., Goios A; P95 Clinical and Epidemiology Services, Louvain, Belgium., Justo N; Thermo Fisher Scientific, Stockholm, Sweden., Lu Y; Thermo Fisher Scientific, London, UK., Quint JK; School of Public Health, Imperial College London, London, UK., Taylor S; Medical Evidence, Vaccines & Immune Therapies, AstraZeneca, Eastbrook House, Shaftesbury Road, Cambridge, CB2 8DU, UK., Venkatesan S; BPM Evidence Statistics, Real World Science and Analytics, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK., Turtle L; Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.
Source: Infectious diseases and therapy [Infect Dis Ther] 2026 May; Vol. 15 (5), pp. 1401-1424. Date of Electronic Publication: 2026 Mar 27.
Publication Type: Journal Article
Journal Info: Publisher: Adis Country of Publication: New Zealand NLM ID: 101634499 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8229 (Print) Linking ISSN: 21936382 NLM ISO Abbreviation: Infect Dis Ther Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41896400
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Post-COVID-19 Burden of Severe Influenza in England Among Overall Population and High-Risk Groups: Results From the INFORM Study, 2022-2023.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Meeraus+W%22">Meeraus W</searchLink>; Medical Evidence, Vaccines & Immune Therapies, AstraZeneca, Eastbrook House, Shaftesbury Road, Cambridge, CB2 8DU, UK. wilhelmine.meeraus@astrazeneca.com.<br /><searchLink fieldCode="AU" term="%22Carty+L%22">Carty L</searchLink>; BPM Evidence Statistics, Real World Science and Analytics, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Dube+S%22">Dube S</searchLink>; Medical Evidence, Vaccines & Immune Therapies, AstraZeneca, Eastbrook House, Shaftesbury Road, Cambridge, CB2 8DU, UK.<br /><searchLink fieldCode="AU" term="%22Evans+K%22">Evans K</searchLink>; Thermo Fisher Scientific, Waltham, MA, USA.<br /><searchLink fieldCode="AU" term="%22Evans+RA%22">Evans RA</searchLink>; Department of Respiratory Sciences, NIHR Biomedical Research Centre-Respiratory Theme, University of Leicester, Leicester, UK.<br /><searchLink fieldCode="AU" term="%22Goios+A%22">Goios A</searchLink>; P95 Clinical and Epidemiology Services, Louvain, Belgium.<br /><searchLink fieldCode="AU" term="%22Justo+N%22">Justo N</searchLink>; Thermo Fisher Scientific, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Lu+Y%22">Lu Y</searchLink>; Thermo Fisher Scientific, London, UK.<br /><searchLink fieldCode="AU" term="%22Quint+JK%22">Quint JK</searchLink>; School of Public Health, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Taylor+S%22">Taylor S</searchLink>; Medical Evidence, Vaccines & Immune Therapies, AstraZeneca, Eastbrook House, Shaftesbury Road, Cambridge, CB2 8DU, UK.<br /><searchLink fieldCode="AU" term="%22Venkatesan+S%22">Venkatesan S</searchLink>; BPM Evidence Statistics, Real World Science and Analytics, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Turtle+L%22">Turtle L</searchLink>; Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101634499%22">Infectious diseases and therapy</searchLink> [Infect Dis Ther] 2026 May; Vol. 15 (5), pp. 1401-1424. <i>Date of Electronic Publication: </i>2026 Mar 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%22">Adis </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101634499 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2193-8229 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221936382%22">21936382 </searchLink><i>NLM ISO Abbreviation: </i>Infect Dis Ther <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41896400
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40121-026-01332-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1401
    Titles:
      – TitleFull: Post-COVID-19 Burden of Severe Influenza in England Among Overall Population and High-Risk Groups: Results From the INFORM Study, 2022-2023.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Meeraus W
      – PersonEntity:
          Name:
            NameFull: Carty L
      – PersonEntity:
          Name:
            NameFull: Dube S
      – PersonEntity:
          Name:
            NameFull: Evans K
      – PersonEntity:
          Name:
            NameFull: Evans RA
      – PersonEntity:
          Name:
            NameFull: Goios A
      – PersonEntity:
          Name:
            NameFull: Justo N
      – PersonEntity:
          Name:
            NameFull: Lu Y
      – PersonEntity:
          Name:
            NameFull: Quint JK
      – PersonEntity:
          Name:
            NameFull: Taylor S
      – PersonEntity:
          Name:
            NameFull: Venkatesan S
      – PersonEntity:
          Name:
            NameFull: Turtle L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2026 May
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2193-8229
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Infectious diseases and therapy
              Type: main
ResultId 1